| Net loss | -14K |
| Equity in net loss of joint venture | 0 |
| Share-based compensation | 309K |
| Stock issued for services | |
| Bad debt (credit) expense | |
| Depreciation and amortization | 1.3M |
| (Gain) loss on disposal of property, plant and equipment | -1.07M |
| Accounts receivable | 551K |
| Inventory | 0 |
| Costs and estimated earnings in excess of billings on uncompleted contracts | |
| Prepaid expenses and other current assets | |
| Other assets | 37K |
| Accounts payable and accrued liabilities | 217K |
| Deferred revenues | |
| Billings in excess of costs and estimated earnings on uncompleted contracts | 2.21M |
| Net cash (used in) provided by operating activities | |
| Purchases of property, plant and equipment | -1.11M |
| Proceeds from sale of property, plant and equipment | 3.8M |
| Cash paid for patents | |
| Investment in cost method securities | |
| Cash paid for capitalized software | |
| Repayments on (cash paid for) note receivable | |
| Net cash used in investing activities | |
| Funds used for purchase of our common stock | -305K |
| Proceeds from sale of common stock | |
| Stock cancelled for payroll taxes | |
| Proceeds from bank term loan | |
| Repayments of long-term debt | -3.05M |
| Net cash (used in) provided by financing activities | |
| Change in cash and equivalents | 6.35M |
| Cash and cash equivalents, beginning of period | |
| Cash and cash equivalents, end of period | |